ArticleAnnals of surgical oncology2025
Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option?
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Current status of endoscopic resection for small rectal neuroendocrine tumors.World journal of gastroenterology · 2025Review
- Surgical Wait Time Is Not Associated With Oncological or Psychosocial Outcomes After Robotic Radical Prostatectomy.Prostate cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundGuidelines for some pancreatic neuroendocrine tumors (NETs) have shifted towards active surveillance given the indolent nature of this malignancy. We sought to assess the safety of delayed surgery on colorectal NETs as a surrogate for surveillance.
methodsResected, stage I, well-differentiated colorectal primary NETs included in the Surveillance, Epidemiology, and End Results Program from 2010 to 2020 were included. Demographics, interval from diagnosis to surgery, and disease-specific survival (DSS) were retrospectively analyzed. Clinical stage I patients in the National Cancer Database were then reviewed to assess the incidence of pathologic upstaging, as well as the impact of active surveillance on overall survival (OS).
resultsOverall, 4275 patients met the inclusion criteria and 33 (0.8%) had disease-specific death; 61 (1.4%) patients had surgery > 6 months after diagnosis. Median DSS and overall follow-up were 34 and 68 months, respectively. Multivariable analysis demonstrated delayed surgery > 6 months (hazard ratio [HR] 4.82 [1.13-20.55], p = 0.033), male sex (HR 3.16 [1.43-7.03], p = 0.005), and age (HR 1.06 [1.03-1.10], p = < 0.001) were associated with increased risk, while having a rectal primary (HR 0.32 [0.15-0.68], p = 0.003) was protective; however, a > 6-month delay remained significant when analyzing rectal primaries alone (HR 4.5 [1-19.2], p = 0.044). Delay in surgery > 6 months was associated with a 14% (p = 0.0023) incidence of upstaging, while active surveillance was associated with decreased OS (HR 1.48 [1.02-2.13], p = 0.039) compared with upfront resection.
conclusionsProlonged delays in surgery > 6 months for colorectal NETs were associated with decreased DSS and a significant risk of upstaging, suggesting that surveillance may not be appropriate even for stage I disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.